Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

News and Trends 3 Jun 2016

Biotech of the Week: High-quality genetic testing with Asper Biotech in Estonia

This week we decided we needed a geographical change and explore slightly different territories… The Baltic sea was a good solution, we thought, so that’s why we are leaving Paris to head up to Tartu, in Estonia, to visit Asper Biotech, our Biotech of the Week. City: Tartu (Estonia) Founded: 1999 Employees: 11 – 50 (as of […]

June 3, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 2 Jun 2016

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

MiNA Therapeutics is launching the first saRNA human trial of its kind – OUTREACH for patients with severe liver cancer. MiNA Therapeutics is a London based RNA specialist, developing RNA activation therapeutics that restore normal function to patients’ cells with an initial focus on severe liver cancer. The study is the first-in-human trial of a small activating RNA […]

June 2, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 2 Jun 2016

First All-Cancer mRNA Vaccine that Works Published in Nature

Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all 13 patients treated with its personalized mRNA cancer vaccine, strengthening its potential to become a universal cancer vaccine. Originally published on 02/06/2016 BioNTech and its academic partners have published in the well-known publication Nature, describing the first clinically applicable and systemic […]

June 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 2 Jun 2016

A ‘Skin Spray’ could cure Chronic Skin Wounds caused by Diabetes

Avita has initiated a trial in the UK to evaluate the potential of its ReGenerCell technology to treat diabetic foot ulcers, a skin wound that can be very hard to treat. With offices in the UK and originally from Australia, Avita Medical is developing products in tissue engineering and regenerative medicine. Its technology utilises the […]

June 2, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 1 Jun 2016

Novel Bionic Vision device gains approval for clinical trials in Renowned UK Hospital

Pixium Vision will be testing its new IRIS II bionic vision system in a clinical trial. The device can mimic eye function in people affected by Retinitis pigmentosa and Macular degeneration. Based in Paris (France), Pixium Vision is developing an alternative for people who have lost their sight – a bionic vision restoration system (VRS). One […]

June 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 1 Jun 2016

EMA approves Groundbreaking Gene Therapy for Super Rare ‘Bubble Baby’ Disease

GSK, Fondazione Telethon and Ospedale San Raffaele have announced that the EMA has approved Strimvelis for a super rare immunodeficiency disease in Children. Following 20 years of research at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Italy, this is the news patients have been waiting for. Strimvelis is the first ex vivo stem cell gene […]

June 1, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT

News and Trends 1 Jun 2016

CRISPR Thx’ Founder: “We have over $250M in the bank”

So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe. Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for […]

June 1, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 31 May 2016

UK Immunotherapy against Grass Allergies moves on to Phase III Trials

Circassia is beginning a Phase III trial for its short-course immunotherapy for grass allergies. This common type of allergy can significantly impact the life quality of patients. Circassia is based in Oxford (UK) and was part of 2014’s record Biotech IPOs – raising a whopping €268M. It focuses on respiratory diseases, such as asthma and allergies. Its […]

May 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 31 May 2016

Asian Super investor claims stake in Microalgae Drink Startup

The French startup Algama has received €3.5M investment from the Hong Kong billionaire, Li Ka-shing, known for his stakes in Facebook, Spotify, and Skype. Based on a microalgae brew, Algama’s nutritional drinks product SpringWave is evidently hitting the marketing mark, by making the algae Spirulina a tasty. But there are many other algae-based products which look to compete in this Omega-3 and […]

May 31, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 31 May 2016

DBV Technologies: “This is our First and most Significant Partnership signed”

The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health Science to develop a new diagnostic test of Milk allergies. This is the first deal of DBV and shows the potential of its technological platform. I had a chat with its COO David Schilansky to find out more… DBV is […]

May 31, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 30 May 2016

Roche debuts new MedTech for needle-free management of Diabetes

Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to sell an implantable glucose sensor in some major European countries. The Diabetes Care division of Swiss big Pharma Roche has more than 35 years of experience, and its Accu-Check devices are one of best-selling diabetes management […]

May 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 30 May 2016

Besides Techno, Berlin is also the place to be for Life Science Industries

On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As we too belong to this city, we are pleased to summarise the highlights of what happened there… This free event, which belongs to the Life Science’s […]

May 30, 2016 - 3 minutesmins - By Jerome Topsent

ADVERTISEMENT